Welcome! This is the NEW free version of the SciBITES Pharma News Engine from SciBite. By using this site you to accept our Terms & Conditions which the use of cookies to enhance your user experience.


Here is the latest news for your query in chronological order, most recent articles at the top. Use the options on the right to filter and customise this news feed.

  Todays Live Pharma News Articles ...

Alere Launches the Alere™ Malaria Ag P.f, the First-Ever Rapid Test to Screen Malaria Infection in Asymptomatic Individuals
http://www.prnewswire.com, , 25-Apr-2017
Sandoz proposed biosimilars recommended for EU approval
https://www.europeanpharmaceuticalreview.com, , 25-Apr-2017
Merck Divests Biosimilars Business to Fresenius
http://www.bionity.com, , 25-Apr-2017
Allergan Granted Marketing Authorization by the FDA for TrueTear™, the First Intranasal Neurostimulating Device Proven to Temporarily Increase Tear Production
http://www.prnewswire.com, , 25-Apr-2017
Pfizer's Zavicefta matches standard-of-care in treating hospital-acquired pneumonia in phase 3 study
http://clinicaltrials.pharmaceutical-business-review.com, , 25-Apr-2017
Newton cancer biotech Karyopharm plans to raise $40M in stock sale
http://feeds.bizjournals.com, , 25-Apr-2017
Fresenius and Merck Stocks Top DAX on Biosimilars Deal
Web News, , 25-Apr-2017
Ex-Kythera team raises $40M for dermatology clinical trials
http://www.fiercebiotech.com, , 25-Apr-2017
New drugs can't keep Novartis sales on the up
http://www.pmlive.com, , 25-Apr-2017
Fresenius Kabi buys Akorn and Merck's biosimilar businesses
http://www.pmlive.com, , 25-Apr-2017
Capricor Therapeutics Announces Positive Six-Month Results from the Randomized Phase I/II HOPE Clinical Trial in Duchenne Muscular Dystrophy
http://www.prnewswire.com, , 25-Apr-2017
Pfizer’s Phase III study to treat hospital-acquired pneumonia a success
https://www.europeanpharmaceuticalreview.com, , 25-Apr-2017
Fresenius Kabi agrees to acquire Akorn for $4.3bn
http://otc.pharmaceutical-business-review.com, , 25-Apr-2017
Servier and CTI BioPharma Expand License and Collaboration Agreement to Develop and Commercialize PIXUVRI®
http://www.prnewswire.com, , 25-Apr-2017
Orexigen Therapeutics Announces New Drug Submission for Contrave© in Canada
http://www.prnewswire.com, , 25-Apr-2017
Certara launches CDISC PK solution
http://www.outsourcing-pharma.com, , 25-Apr-2017
FDA Clears Second Remicade Biosimilar
http://www.rxlist.com, , 25-Apr-2017
Novartis real-world data at AAN confirms benefit of Gilenya® on four key measures of disease activity in relapsing MS
http://www.worldpharmanews.com, , 25-Apr-2017
Certara launches CDISC PK solution
Capricor Therapeutics to Report Six-Month Results from the Randomized Phase I/II HOPE Clinical Trial in Duchenne Muscular Dystrophy
http://www.prnewswire.com, , 24-Apr-2017
Showing Records 0 ... 20  


SciBite
The Language Of Science

SciBite provides text-analytics and data intelligence software for drug discovery, clinical and competitor intelligence and much more for pharma, healthcare and life sciences.

This is a Limited, Free Service only touching the surface of how SciBite's tools transform biomedical text, literature, patents, internal documents and news into a rich intelligence network. If you'd like to know more, contact us to see how our tools can transform your work today!

Topic Activity & Tools

Get Daily Alerts!

Click For Email & RSS Alerts

About/Links

Query: Live Pharma News
Type: Query